AUPH logo

Aurinia Pharmaceuticals (AUPH) Cash from investing

annual CFI:

$39.26M+$45.97M(+685.48%)
December 31, 2024

Summary

  • As of today (June 1, 2025), AUPH annual cash flow from investing activities is $39.26 million, with the most recent change of +$45.97 million (+685.48%) on December 31, 2024.
  • During the last 3 years, AUPH annual CFI has risen by +$143.13 million (+137.80%).
  • AUPH annual CFI is now at all-time high.

Performance

AUPH Cash from investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAUPHcash flow metrics

quarterly CFI:

$31.03M-$8.19M(-20.88%)
March 31, 2025

Summary

  • As of today (June 1, 2025), AUPH quarterly cash flow from investing activities is $31.03 million, with the most recent change of -$8.19 million (-20.88%) on March 31, 2025.
  • Over the past year, AUPH quarterly CFI has dropped by -$18.20 million (-36.97%).
  • AUPH quarterly CFI is now -64.31% below its all-time high of $86.96 million, reached on December 31, 2017.

Performance

AUPH quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAUPHcash flow metrics

TTM CFI:

$21.06M-$18.20M(-46.36%)
March 31, 2025

Summary

  • As of today (June 1, 2025), AUPH TTM cash flow from investing activities is $21.06 million, with the most recent change of -$18.20 million (-46.36%) on March 31, 2025.
  • Over the past year, AUPH TTM CFI has increased by +$3.39 million (+19.21%).
  • AUPH TTM CFI is now -70.26% below its all-time high of $70.82 million, reached on September 30, 2018.

Performance

AUPH TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAUPHcash flow metrics

Cash from investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

AUPH Cash from investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+685.5%-37.0%+19.2%
3 y3 years+137.8%+158.5%+123.5%
5 y5 years+404.5%+355.9%+355.8%

AUPH Cash from investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+137.8%-37.0%+158.5%-46.4%+123.5%
5 y5-yearat high+124.8%-37.0%+121.5%-46.4%+109.9%
alltimeall timeat high+124.8%-64.3%+121.5%-70.3%+109.9%

AUPH Cash from investing History

DateAnnualQuarterlyTTM
Mar 2025
-
$31.03M(-20.9%)
$21.06M(-46.4%)
Dec 2024
$39.26M(-685.5%)
$39.22M(-471.0%)
$39.26M(-731.4%)
Sep 2024
-
-$10.57M(-72.6%)
-$6.22M(-59.5%)
Jun 2024
-
-$38.62M(-178.4%)
-$15.35M(-186.9%)
Mar 2024
-
$49.23M(-886.8%)
$17.67M(-363.5%)
Dec 2023
-$6.71M(-88.9%)
-$6.26M(-68.2%)
-$6.71M(+93.4%)
Sep 2023
-
-$19.70M(+251.3%)
-$3.47M(-89.8%)
Jun 2023
-
-$5.61M(-122.6%)
-$33.98M(-297.1%)
Mar 2023
-
$24.86M(-923.7%)
$17.25M(-128.4%)
Dec 2022
-$60.63M(-41.6%)
-$3.02M(-94.0%)
-$60.63M(-3.9%)
Sep 2022
-
-$50.22M(-210.1%)
-$63.10M(+38.1%)
Jun 2022
-
$45.62M(-186.0%)
-$45.69M(-49.0%)
Mar 2022
-
-$53.02M(+866.2%)
-$89.64M(-13.7%)
Dec 2021
-$103.87M(-34.3%)
-$5.49M(-83.3%)
-$103.87M(+31.1%)
Sep 2021
-
-$32.81M(-2064.4%)
-$79.24M(-58.5%)
Jun 2021
-
$1.67M(-102.5%)
-$190.93M(-10.5%)
Mar 2021
-
-$67.25M(-451.2%)
-$213.31M(+34.8%)
Dec 2020
-$158.19M(-2132.5%)
$19.15M(-113.3%)
-$158.19M(-10.8%)
Sep 2020
-
-$144.50M(+597.7%)
-$177.36M(+439.2%)
Jun 2020
-
-$20.71M(+70.8%)
-$32.89M(+299.5%)
Mar 2020
-
-$12.13M(>+9900.0%)
-$8.23M(-205.8%)
Dec 2019
$7.78M(<-9900.0%)
-$29.00K(-3.3%)
$7.78M(-67.4%)
Sep 2019
-
-$30.00K(-100.8%)
$23.88M(+34.0%)
Jun 2019
-
$3.95M(+1.6%)
$17.83M(-25.2%)
Mar 2019
-
$3.89M(-75.8%)
$23.85M(<-9900.0%)
Dec 2018
-$65.00K(-99.2%)
$16.07M(-364.1%)
-$65.00K(-100.1%)
Sep 2018
-
-$6.08M(-161.0%)
$70.82M(-987.3%)
Jun 2018
-
$9.97M(-149.8%)
-$7.98M(-68.0%)
Mar 2018
-
-$20.02M(-123.0%)
-$24.98M(+212.1%)
Dec 2017
-$8.00M(-180.1%)
$86.96M(-202.4%)
-$8.00M(-91.3%)
Sep 2017
-
-$84.89M(+1108.4%)
-$91.93M(+1199.1%)
Jun 2017
-
-$7.03M(+130.5%)
-$7.08M(-277.5%)
Mar 2017
-
-$3.05M(-200.4%)
$3.99M(-60.1%)
Dec 2016
$9.99M(<-9900.0%)
$3.04M(-7884.6%)
$9.99M(+43.7%)
Sep 2016
-
-$39.00K(-101.0%)
$6.96M(-0.8%)
Jun 2016
-
$4.04M(+36.6%)
$7.01M(+138.2%)
Mar 2016
-
$2.96M(>+9900.0%)
$2.94M(<-9900.0%)
Dec 2015
-$23.00K(-99.8%)
$0.00(-100.0%)
-$23.00K(-46.5%)
Sep 2015
-
$19.00K(-161.3%)
-$43.00K(-99.6%)
Jun 2015
-
-$31.00K(+181.8%)
-$10.07M(-0.2%)
Mar 2015
-
-$11.00K(-45.0%)
-$10.09M(+0.1%)
Dec 2014
-$10.08M(>+9900.0%)
-$20.00K(-99.8%)
-$10.08M(+0.0%)
Sep 2014
-
-$10.01M(>+9900.0%)
-$10.08M(>+9900.0%)
Jun 2014
-
-$47.00K(<-9900.0%)
-$96.00K(0.0%)
Mar 2014
-
$0.00(-100.0%)
-$96.00K(+166.7%)
Dec 2013
-$36.00K(+15.4%)
-$19.00K(-36.7%)
-$36.00K(+34.3%)
Sep 2013
-
-$30.00K(-36.2%)
-$26.80K(+6600.0%)
Jun 2013
-
-$47.00K(-178.3%)
-$400.00(-100.0%)
Mar 2013
-
$60.00K(-712.2%)
$888.90K(-2958.2%)
Dec 2012
-$31.20K(-97.3%)
-$9800.00(+172.2%)
-$31.10K(-70.7%)
Sep 2012
-
-$3600.00(-100.4%)
-$106.30K(+115.6%)
Jun 2012
-
$842.30K(-197.9%)
-$49.30K(-94.6%)
Mar 2012
-
-$860.00K(+911.8%)
-$920.20K(-20.0%)
DateAnnualQuarterlyTTM
Dec 2011
-$1.15M(-166.3%)
-$85.00K(-259.2%)
-$1.15M(+11.8%)
Sep 2011
-
$53.40K(-286.7%)
-$1.03M(-4.1%)
Jun 2011
-
-$28.60K(-97.4%)
-$1.07M(-4.3%)
Mar 2011
-
-$1.09M(-3071.7%)
-$1.12M(-164.6%)
Dec 2010
$1.74M(-1162.9%)
$36.70K(+290.4%)
$1.74M(+5.4%)
Sep 2010
-
$9400.00(-112.2%)
$1.65M(+8.0%)
Jun 2010
-
-$77.10K(-104.4%)
$1.52M(-70.3%)
Mar 2010
-
$1.77M(-3497.5%)
$5.14M(-3246.3%)
Dec 2009
-$163.30K(-51.0%)
-$52.00K(-54.0%)
-$163.40K(-22.4%)
Sep 2009
-
-$113.10K(-103.2%)
-$210.70K(+35.1%)
Jun 2009
-
$3.54M(-200.0%)
-$156.00K(-95.9%)
Mar 2009
-
-$3.54M(+3462.6%)
-$3.80M(+1038.0%)
Dec 2008
-$333.60K(-103.6%)
-$99.30K(+70.0%)
-$333.60K(-111.7%)
Sep 2008
-
-$58.40K(-42.2%)
$2.85M(-39.7%)
Jun 2008
-
-$101.10K(+35.2%)
$4.73M(-33.8%)
Mar 2008
-
-$74.80K(-102.4%)
$7.14M(-22.7%)
Dec 2007
$9.23M(-51.5%)
$3.09M(+69.7%)
$9.23M(-9.6%)
Sep 2007
-
$1.82M(-21.2%)
$10.21M(-26.9%)
Jun 2007
-
$2.31M(+14.4%)
$13.96M(-14.6%)
Mar 2007
-
$2.02M(-50.3%)
$16.36M(-14.0%)
Dec 2006
$19.02M(+159.5%)
$4.06M(-27.1%)
$19.02M(+9.5%)
Sep 2006
-
$5.57M(+18.5%)
$17.37M(+90.7%)
Jun 2006
-
$4.70M(+0.4%)
$9.11M(+23.5%)
Mar 2006
-
$4.68M(+94.5%)
$7.38M(+0.6%)
Dec 2005
$7.33M(+648.1%)
$2.41M(-189.7%)
$7.33M(+91.5%)
Sep 2005
-
-$2.68M(-190.3%)
$3.83M(+30.2%)
Jun 2005
-
$2.97M(-35.9%)
$2.94M(-66.4%)
Mar 2005
-
$4.64M(-523.0%)
$8.75M(+793.1%)
Dec 2004
$979.90K(-106.8%)
-$1.10M(-69.3%)
$979.90K(-108.6%)
Sep 2004
-
-$3.57M(-140.7%)
-$11.43M(+53.6%)
Jun 2004
-
$8.78M(-380.1%)
-$7.44M(-56.7%)
Mar 2004
-
-$3.14M(-76.8%)
-$17.20M(+19.3%)
Dec 2003
-$14.41M(-36.1%)
-$13.51M(-3332.7%)
-$14.41M(-15.6%)
Sep 2003
-
$417.80K(-142.7%)
-$17.08M(-21.4%)
Jun 2003
-
-$978.40K(+182.1%)
-$21.72M(+2.4%)
Mar 2003
-
-$346.80K(-97.9%)
-$21.22M(-5.8%)
Dec 2002
-$22.54M(-998.8%)
-$16.17M(+282.9%)
-$22.54M(+254.0%)
Sep 2002
-
-$4.22M(+781.7%)
-$6.37M(-1.5%)
Jun 2002
-
-$479.10K(-71.2%)
-$6.46M(+3.7%)
Mar 2002
-
-$1.66M(-61.5%)
-$6.23M(-45.9%)
Dec 2001
$2.51M(-134.6%)
-
-
Aug 2001
-
-$4.32M(+1634.9%)
-$11.53M(+59.5%)
May 2001
-
-$249.00K(+98.2%)
-$7.23M(-0.2%)
Feb 2001
-
-$125.60K(-98.2%)
-$7.24M(-0.2%)
Nov 2000
-$7.25M(+5240.8%)
-$6.84M(>+9900.0%)
-$7.25M(+1631.8%)
Aug 2000
-
-$16.40K(-93.8%)
-$418.80K(-21.9%)
May 2000
-
-$262.60K(+90.6%)
-$536.20K(+96.0%)
Feb 2000
-
-$137.80K(+6790.0%)
-$273.60K(+101.5%)
Nov 1999
-$135.80K(+108.6%)
-$2000.00(-98.5%)
-$135.80K(+1.5%)
Aug 1999
-
-$133.80K(<-9900.0%)
-$133.80K(<-9900.0%)
May 1999
-
$0.00(0.0%)
$0.00(0.0%)
Feb 1999
-
$0.00
$0.00
Nov 1998
-$65.10K
-
-

FAQ

  • What is Aurinia Pharmaceuticals annual cash flow from investing activities?
  • What is the all time high annual CFI for Aurinia Pharmaceuticals?
  • What is Aurinia Pharmaceuticals annual CFI year-on-year change?
  • What is Aurinia Pharmaceuticals quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Aurinia Pharmaceuticals?
  • What is Aurinia Pharmaceuticals quarterly CFI year-on-year change?
  • What is Aurinia Pharmaceuticals TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Aurinia Pharmaceuticals?
  • What is Aurinia Pharmaceuticals TTM CFI year-on-year change?

What is Aurinia Pharmaceuticals annual cash flow from investing activities?

The current annual CFI of AUPH is $39.26M

What is the all time high annual CFI for Aurinia Pharmaceuticals?

Aurinia Pharmaceuticals all-time high annual cash flow from investing activities is $39.26M

What is Aurinia Pharmaceuticals annual CFI year-on-year change?

Over the past year, AUPH annual cash flow from investing activities has changed by +$45.97M (+685.48%)

What is Aurinia Pharmaceuticals quarterly cash flow from investing activities?

The current quarterly CFI of AUPH is $31.03M

What is the all time high quarterly CFI for Aurinia Pharmaceuticals?

Aurinia Pharmaceuticals all-time high quarterly cash flow from investing activities is $86.96M

What is Aurinia Pharmaceuticals quarterly CFI year-on-year change?

Over the past year, AUPH quarterly cash flow from investing activities has changed by -$18.20M (-36.97%)

What is Aurinia Pharmaceuticals TTM cash flow from investing activities?

The current TTM CFI of AUPH is $21.06M

What is the all time high TTM CFI for Aurinia Pharmaceuticals?

Aurinia Pharmaceuticals all-time high TTM cash flow from investing activities is $70.82M

What is Aurinia Pharmaceuticals TTM CFI year-on-year change?

Over the past year, AUPH TTM cash flow from investing activities has changed by +$3.39M (+19.21%)
On this page